Literature DB >> 24217010

Properly selected skin cancer treatments are very effective.

Howard W Rogers1, Eric Armbrecht2, Brett M Coldiron3, John Albertini4, Michel McDonald5, Scott M Dinehart6, Ali Hendi7, George Hruza8, Scott W Fosko8, Brent R Moody9.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24217010     DOI： 10.1038/jid.2013.449

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  8 in total

1.  Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.

Authors:  Leslie S Wilson; Mark Pregenzer; Rituparna Basu; Daniel Bertenthal; Jeanette Torres; Maryam Asgari; Mary-Margaret Chren
Journal:  Dermatol Surg       Date:  2011-12-06       Impact factor: 3.398

2.  Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face.

Authors:  Clark C Otley
Journal:  Arch Dermatol       Date:  2006-09

3.  Letter: Skin cancer treatment fee comparisons inaccurate.

Authors:  Howard W Rogers; Brett M Coldiron; Scott M Dinehart; Ali Hendi; George Hruza; Scott W Fosko; Brent R Moody
Journal:  Dermatol Surg       Date:  2012-12       Impact factor: 3.398

4.  Cost effectiveness of Mohs micrographic surgery.

Authors:  Robert S Stern
Journal:  J Invest Dermatol       Date:  2013-05       Impact factor: 8.551

5.  A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.

Authors:  Howard W Rogers; Brett M Coldiron
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

6.  Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.

Authors:  Brigitte A B Essers; Carmen D Dirksen; Fred H M Nieman; Nicole W J Smeets; Gertrude A M Krekels; Martin H Prins; H A Martino Neumann
Journal:  Arch Dermatol       Date:  2006-02

7.  Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.

Authors:  Klara Mosterd; Gertruud A M Krekels; Fred Hm Nieman; Judith U Ostertag; Brigitte A B Essers; Carmen D Dirksen; Peter M Steijlen; Anton Vermeulen; Ham Neumann; Nicole W J Kelleners-Smeets
Journal:  Lancet Oncol       Date:  2008-11-17       Impact factor: 41.316

8.  Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Eleni Linos; Jeanette S Torres; Sarah E Stuart; Rupa Parvataneni; W John Boscardin
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551
  8 in total
  1 in total

1.  Response to Rogers et al.

Authors:  Robert S Stern
Journal:  J Invest Dermatol       Date:  2013-10-30       Impact factor: 8.551
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.